Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

In an effort to help smokers in their journey to quit smoking Nicotex, the market leader in smoking cessation has launched ...

Equity benchmark indices fluctuated amid mixed global gues. Sensex declined 149.97 pts or 0.18 per cent to 81,180.59 as at 12 ...

The proposed 10% tariff, which mirrors India’s tax on US drug imports, could severely impact profit margins for generic drug ...

Beyond the Shs211b earned from selling shares during the 2023 IPO, Airtel also made a “paper gain” of $49m (Shs179b) ...

FY25 net profit beat expectations due to higher other income and a lower tax outgo, EBITDA came in slightly below estimates because of increased R&D expenditure.

The Mumbai-based drug firm had reported a net profit of Rs 939 crore for the January-March period a year ago. Total revenue ...

Cipla also allayed concerns that the US government's drug pricing executive order on pharma companies, aimed at lowering cost ...

Macquarie views guidance as conservative, especially since Cipla has consistently outperformed its own forecasts over the ...

Vohra stated that the directive appears to be primarily aimed at branded pharmaceutical products rather than generic ...

For the new financial year, Cipla expects its topline to see "continued growth trajectory" and the management fell short of ...

The pharmaceutical segment contributed Rs 6,503.63 crore to the quarterly revenue, reflecting an 8.5 per cent growth, while ...